HSE - Scientific Advisory Committee on Genetically Modified Organisms
(SACGM)
Fifth Meeting of the Scientific Advisory Committee on Genetic Modification (Contained Use)
1 st June 2005, 10.30am – 1.30pm
The Rose Room, Rose Court, Southwark Bridge, London
AGENDA
1. Welcome & apologies
2. Introduction to the 1 st Open Meeting of SACGM
3. Minutes of the previous meeting
4. Matters arising
5. Secretariat Report
6. Regulatory issues relating to the application of reverse genetics – example of human influenza virus vaccine
7. Notifications for information and discussion
- Class 4 activity notification “ Genetic Manipulation of Foot & Mouth Disease Virus (FMDV) ”;
- Class 2 activity notification involving the technique of siRNA “ Investigation into the role of downstream components of the FGFR cell signalling pathway in primary human cells ”;
- First notification of a contained use Biopharming activity “ Expression of human endostatin peptide in Nicotiana benthamiana and Nicotiana tabacum plants using potato virus X (PVX) and tobacco mosaic virus (TMV) ”.
8. Public Feedback Session – Question & Answers on issues discussed at this Open Meeting or organisation/functioning of SACGM
9. Concluding remarks
10. Close
